Anti-Human MAPK9 Antibody [B269]
Anti-Human MAPK9 Antibody [B269] with collaborator-tested evidence for WB, IP. Read more ›
["WBProduct Description
MAPK9 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Monoclonal; clone: B269; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for WB, IP. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Recombinant Human JNK2/MAPK9 Protein; purification: Protein A; concentration: 1 mg/mL.
Database references: UniProt: P45984.
Research Use Only.
Key Facts
| Target | MAPK9 |
| Also known as | MAPK, PRKM, JNK, MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK, c Jun kinase 2, C Jun N terminal kinase 2, c-Jun N-terminal kinase 2, JNK 55, JNK2 alpha, JNK2 beta, Jun kinase, MAP kinase 9, MAPK 9, Mitogen activated protein kinase 9, mitogen-activated, Mitogen-activated protein kinase 9, MK09, Protein kinase, SAPK alpha, Stress activated protein kinase 1a, Stress-activated protein kinase JNK2 |
| Concentration | 1 mg/mL |
| Species reactivity | Human |
| Observed band | 54 kDa |
| Shelf life | 12 months from shipping dates |
| Research area | Signal Transduction, Cell Biology, Cancer, Immunology, Metabolism, Epigenetics and Nuclear Signaling |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | |
|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.